Skip to content

AYTU - AYTU BIOPHARMA, INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Aytu BioScience Inc

AYTU · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

AYTUAytu BioScience Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.07
52-wk low: $1.65
Prev close: $2.25
Mkt cap: $25.3M
Fwd P/E: 29.6x
Beta: 0.26

Smart money

6 funds hold a position.

Real smart money

Funds holding this stock

6 holders

Combined position$608K

TS
Two Sigma
Q2 2026 13F
$226K
position
JS
Jim Simons
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -60.2%
Forward P/E: 29.59
Market cap: $25M

Valuation

P/S0.45
P/B0.72

Quality

Operating margin-32.7%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: AYTU
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $25.33M
Beta: 0.26

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

0.4x

P/B

0.7x

Profit margin

-60.2%

Op margin

-32.7%

ROE

-97.4%

$225K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$106K

position

3 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 3 holders

Coverage gaps for AYTU

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

Reports Sep 22, 2026, in 32 days

EPS expected

-$0.02

-$0.02 to -$0.02

Revenue expected

$17.2M

1 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

0.02

Change in 30 days

ROE

-97.4%

ROA-3.7%

Growth

Beta0.26